Support for HIV persistence and cure research

Accelevir has established a centralized specialty testing resource – supported by a cooperative agreement with the National Institute of Allergy and Infectious Diseases (NIAID U24AI143502). Under this program Accelevir offers a comprehensive suite of molecular assays and virology services which include: